Sichenzia Ross Ference Kesner LLP代表PolarityTE，Inc.以3740万美元公开发售
Press Release – New York, NY – April 16, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented PolarityTE, Inc. (“NASDAQ. COOL”) in a $37.4 million public offering of common stock. A total of 2,335,937 shares of common stock were sold at a price of $16.00 per share, which includes shares sold upon exercise of the underwriters’ over-allotment option. Cantor Fitzgerald & Co. acted as the sole book-running manager for the offering. PolarityTE is a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products for the fields of medicine, biomedical engineering and material sciences. The Sichenzia Ross Ference Kesner LLP team was led by Partners Harvey Kesner and Tara Guarneri-Ferrara and associate Evan Berger.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- 创始合伙人Gregory Sichenzia专注于商业内幕人士讨论Elon Musk的推文和证券合法性 - August 8, 2018
- Anthony Ciaccio - July 6, 2018
- Sichenzia Ross Ference Kesner LLP以4.75美元的债务交易代表New Age Beverages Corporation - June 26, 2018